​
​

NeuroBo Pharmaceuticals Ownership | Who Owns NeuroBo Pharmaceuticals?

OverviewRevenueFinancialsChart

NeuroBo Pharmaceuticals Ownership Summary

NeuroBo Pharmaceuticals is owned by 4.59% institutional investors, and 95.41% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.38% of its assets in NeuroBo Pharmaceuticals shares.

NRBO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeuroBo Pharmaceuticals4.59%-95.41%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2022166.67%1,223,591-8.13%418.39%5-16.67%4-33.33%
Mar 31, 202215-16.67%1,331,901-21.22%49.36%6-14.29%650.00%
Dec 31, 202118-1,690,568125.74%764.69%7-4-33.33%
Sep 30, 202118-37.93%748,888-12.82%322.45%7-53.33%6-40.00%
Jun 30, 202129-14.71%858,997-42.44%38.12%15-25.00%1066.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv32.43K0.38%-
Vanguard Institutional Extnd Mkt Idx Tr28.02K0.33%-
Fidelity Extended Market Index20.01K0.24%1.26K
Northern Trust Extended Eq Market Idx7.08K0.08%-
NT Ext Equity Mkt Idx Fd - L7.08K0.08%-
NT Ext Equity Mkt Idx Fd - NL6.38K0.08%-
NT Ext Equity Mkt Idx Fd - DC - NL - T25.14K0.06%16.00
Fidelity Nasdaq Composite Index4.86K0.06%-
Fidelity Series Total Market Index4.67K0.06%1.30K
BlackRock Extended Equity Market K4.52K0.05%-2.00

Recent Insider Transactions

DateNameRoleActivityValue
Sep 12, 2024DONG-A ST CO., LTD-Sell$1.53K
Sep 18, 2024DONG-A ST CO., LTD-Buy$10.00M
Sep 18, 2024DONG-A ST CO., LTD-Buy$15.00M
Jun 23, 2024DONG-A ST CO., LTD-Buy$10.00M
Jun 23, 2024DONG-A ST CO., LTD-Buy$7.96M

Insider Transactions Trends

DateBuySell
2024 Q321
2024 Q22-
2024 Q1--
2023 Q4--
2023 Q3--

NRBO Ownership FAQ

Who Owns NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals shareholders are primarily institutional investors at 4.59%, followed by 0% insiders and 0% retail investors. The average institutional ownership in NeuroBo Pharmaceuticals's industry, Biotech Stocks , is 44.70%, which NeuroBo Pharmaceuticals falls below.

Does Blackrock own NeuroBo Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of NeuroBo Pharmaceuticals.

Who is the top mutual fund holder of NeuroBo Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of NeuroBo Pharmaceuticals shares, with 0.38% of its total shares outstanding invested in 32.43K NeuroBo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools